Liu, S., Lan, B., Wang, Y., Yang, T., Li, L., Ge, H., . . . Ma, F. Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: Insights from the PHILA trialResearch in context. Elsevier.
Chicago Style (17th ed.) CitationLiu, Shuning, et al. Pyrotinib and Trastuzumab Combination Treatment Synergistically Overcomes HER2 Dependency in HER2-positive Breast Cancer: Insights from the PHILA TrialResearch in Context. Elsevier.
MLA (9th ed.) CitationLiu, Shuning, et al. Pyrotinib and Trastuzumab Combination Treatment Synergistically Overcomes HER2 Dependency in HER2-positive Breast Cancer: Insights from the PHILA TrialResearch in Context. Elsevier.
Warning: These citations may not always be 100% accurate.